Strong Buy HIMS by Feb 6, 2026.

Hi Everyone, I believe $HIMS deserves a re-rating meaning a different valuation and narrative that it is now getting. This company made initial headlines on weight loss medicine (shots and now pills) and this created the initial rally. After it became clear that HIMS will not be distributing the NVO wegovy products anymore in June last year, many thought that HIMS would be losing most of its clients and therefore revenue and marketshare. To add, the company also stated that …